These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 6503214)

  • 81. Skin reactions to long-term transdermal clonidine.
    Dick JB; Northridge DB; Lawson AA
    Lancet; 1987 Feb; 1(8531):516. PubMed ID: 2881081
    [No Abstract]   [Full Text] [Related]  

  • 82. Transdermal clonidine for the treatment of essential hypertension.
    McChesney JA; Ryan C; Shaw RE; Fishman-Rosen J; Murphy MC
    Compr Ther; 1987 Apr; 13(4):49-53. PubMed ID: 3568603
    [No Abstract]   [Full Text] [Related]  

  • 83. Transdermal fentanyl. A review of its pharmacological properties and therapeutic efficacy in pain control.
    Jeal W; Benfield P
    Drugs; 1997 Jan; 53(1):109-38. PubMed ID: 9010652
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Clinical acceptability of transdermal clonidine: a large-scale evaluation by practitioners.
    Hollifield J
    Am Heart J; 1986 Oct; 112(4):900-6. PubMed ID: 2945414
    [No Abstract]   [Full Text] [Related]  

  • 85. Antihypertensive effects of clonidine.
    Lilja M; Jounela AJ; Juustila H; Marvola M
    Clin Pharmacol Ther; 1979 Jun; 25(6):864-9. PubMed ID: 376210
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Clonidine in hypertension: a 6-year review.
    Lawson AA; Keston M
    Curr Med Res Opin; 1979; 6(3):168-74. PubMed ID: 520022
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Relationship between the cardiovascular effects and steady-state kinetics of clonidine in hypertension. Demonstration of a therapeutic window in man.
    Frisk-Holmberg M; Paalzow L; Wibell L
    Eur J Clin Pharmacol; 1984; 26(3):309-13. PubMed ID: 6734692
    [TBL] [Abstract][Full Text] [Related]  

  • 88. In vitro/in vivo functionality of Catapres-TTS.
    Enscore DJ; Osborne JL; Shaw JE
    Methods Find Exp Clin Pharmacol; 1989 Mar; 11(3):173-8. PubMed ID: 2657275
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Comparison of intramuscularly and intravenously administered clonidine in the treatment of severe hypertension.
    Russ GR; Whitworth JA; Kincaid-Smith P
    Med J Aust; 1983 Sep; 2(5):229-31. PubMed ID: 6678385
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The effectiveness of clonidine as an antihypertensive in a two-dose regimen.
    Frisk-Holmberg M
    Acta Med Scand; 1980; 207(1-2):43-5. PubMed ID: 7368971
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Allergic contact dermatitis to transdermal clonidine.
    Grattan CE; Kennedy CT
    Contact Dermatitis; 1985 Apr; 12(4):225-6. PubMed ID: 3160534
    [No Abstract]   [Full Text] [Related]  

  • 92. Dose linearity of clonidine after transdermal application.
    Wallenstein G; Gladigau V
    Clin Auton Res; 1993 Dec; 3(6):369-72. PubMed ID: 8193523
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Pharmacokinetics and pharmacodynamics of a new transdermal clonidine, M-5041T, in healthy subjects.
    Fujimura A; Ebihara A; Shiga T; Kumagai Y; Ohashi K; Nakashima H; Kotegawa T
    J Clin Pharmacol; 1993 Dec; 33(12):1192-200. PubMed ID: 8126254
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Transdermal clonidine.
    Saad N; Rybak MJ
    Drug Intell Clin Pharm; 1986 Jan; 20(1):78. PubMed ID: 3943463
    [No Abstract]   [Full Text] [Related]  

  • 95. Old wine into new bottles. A critical evaluation of transdermal clonidine in the treatment of hypertension.
    Mathias CJ
    Clin Auton Res; 1993 Dec; 3(6):355. PubMed ID: 8193520
    [No Abstract]   [Full Text] [Related]  

  • 96. Contact allergies induced by TTS-treatment.
    Eichelberg D; Stolze P; Block M; Buchkremer G
    Methods Find Exp Clin Pharmacol; 1989 Mar; 11(3):223-5. PubMed ID: 2725120
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Pharmacokinetic comparison of a slow-release clonidine with a conventional formulation after acute and chronic administration in hypertensives.
    Conway EL; Anavekar SN; Howes LG; Louis WJ
    J Clin Pharmacol; 1992 May; 32(5):427-33. PubMed ID: 1587960
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Pharmacokinetic interpretation of the plasma levels of clonidine following transdermal delivery.
    Guy RH; Hadgraft J
    J Pharm Sci; 1985 Sep; 74(9):1016-8. PubMed ID: 4067843
    [No Abstract]   [Full Text] [Related]  

  • 99. Relationship between clonidine kinetics and its blood pressure effects.
    Frisk-Holmberg M; Paalzow L
    Acta Med Scand Suppl; 1979; 625():68-73. PubMed ID: 285578
    [No Abstract]   [Full Text] [Related]  

  • 100. Influence of application site of a new transdermal clonidine, M-5041T, on its pharmacokinetics and pharmacodynamics in healthy subjects.
    Ebihara A; Fujimura A; Ohashi K; Shiga T; Kumagai Y; Nakashima H; Kotegawa T
    J Clin Pharmacol; 1993 Dec; 33(12):1188-91. PubMed ID: 8126253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.